DK0463064T3 - Neuronale nicotinacethylcholinreceptorsammensætninger indeholdende beta-4-underenheden - Google Patents

Neuronale nicotinacethylcholinreceptorsammensætninger indeholdende beta-4-underenheden

Info

Publication number
DK0463064T3
DK0463064T3 DK90905079T DK90905079T DK0463064T3 DK 0463064 T3 DK0463064 T3 DK 0463064T3 DK 90905079 T DK90905079 T DK 90905079T DK 90905079 T DK90905079 T DK 90905079T DK 0463064 T3 DK0463064 T3 DK 0463064T3
Authority
DK
Denmark
Prior art keywords
subunit
nicotinic acetylcholine
acetylcholine receptor
neuronal nicotinic
beta
Prior art date
Application number
DK90905079T
Other languages
English (en)
Inventor
Stephen Fox Heinemann
Evan Samuel Deneris
Robert Michael Duvoisin
James Warner Patrick
Original Assignee
Salk Inst For Biological Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi
Application granted granted Critical
Publication of DK0463064T3 publication Critical patent/DK0463064T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
DK90905079T 1989-03-14 1990-03-14 Neuronale nicotinacethylcholinreceptorsammensætninger indeholdende beta-4-underenheden DK0463064T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32138489A 1989-03-14 1989-03-14
US49255590A 1990-03-12 1990-03-12
PCT/US1990/001403 WO1990010648A1 (en) 1989-03-14 1990-03-14 Neuronal nicotinic acetylcholine receptor compositions containing the beta4 subunit

Publications (1)

Publication Number Publication Date
DK0463064T3 true DK0463064T3 (da) 1999-11-29

Family

ID=26982940

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90905079T DK0463064T3 (da) 1989-03-14 1990-03-14 Neuronale nicotinacethylcholinreceptorsammensætninger indeholdende beta-4-underenheden

Country Status (8)

Country Link
US (1) US5789196A (da)
EP (1) EP0463064B1 (da)
JP (1) JP3102877B2 (da)
AT (1) ATE182360T1 (da)
CA (1) CA2047683C (da)
DE (1) DE69033214T2 (da)
DK (1) DK0463064T3 (da)
WO (1) WO1990010648A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440681B1 (en) 1990-04-03 2002-08-27 Merck & Co., Inc. Methods for identifying agonists and antagonists for human neuronal nicotinic acetylcholine receptors
US5369028A (en) * 1990-04-03 1994-11-29 The Salk Institute Biotechnology/Industrial Associates, Inc. DNA and mRNA encoding human neuronal nicotinic acetylcholine receptor compositions and cells transformed with same
DE69434067T2 (de) * 1993-03-08 2006-03-02 Merck & Co., Inc. Menschliche neuronale nikotin-acetylcholin-rezeptor-verbindungen und methoden ihres einsatzes
GB2308121B (en) * 1993-03-08 1997-09-10 Sibia Neurosciences Inc Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
AU1091595A (en) * 1993-11-08 1995-05-29 Salk Institute Biotechnology/Industrial Associates, Inc., The Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
US6485967B1 (en) 1995-06-07 2002-11-26 Merck & Co., Inc. Human neuronal nicotinic acetylcholine receptor α6 and β3 nucleic acid
AUPQ749100A0 (en) * 2000-05-12 2000-06-08 Bionomics Limited New epilespy gene
EP1499350A4 (en) 2001-08-31 2006-02-08 Agensys Inc NUCLEIC ACID AND ASSOCIATED PROTEIN HAVING NAME 205P1B5 FOR USE IN THE TREATMENT AND DETECTION OF CANCER
US7879913B2 (en) * 2005-06-28 2011-02-01 Catholic Healthcare West Iptakalim hydrochloride for decreasing nicotine use
KR20110091501A (ko) 2008-10-14 2011-08-11 싸이코제닉스 아이엔씨. 니코틴성 아세틸콜린 수용체 리간드 및 이들의 용도
KR101602781B1 (ko) 2014-08-28 2016-03-11 주식회사 투에이취켐 미끄럼 방지 바닥재 및 이를 이용한 바닥 시공 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518527A (en) * 1983-08-16 1985-05-21 Mitsubishi Chemical Industries Limited Polypeptides related to the pre-acetylcholine receptor-α of the electric organ of Torpedo californica
US5449606A (en) * 1988-03-18 1995-09-12 The Salk Institute For Biological Studies DNA encoding neuronal nicotinic acetylcholine receptor compositions containing the beta 4 subunit

Also Published As

Publication number Publication date
ATE182360T1 (de) 1999-08-15
WO1990010648A1 (en) 1990-09-20
US5789196A (en) 1998-08-04
DE69033214T2 (de) 1999-12-09
CA2047683A1 (en) 1990-09-15
EP0463064B1 (en) 1999-07-21
JP3102877B2 (ja) 2000-10-23
EP0463064A1 (en) 1992-01-02
DE69033214D1 (de) 1999-08-26
EP0463064A4 (en) 1992-08-19
CA2047683C (en) 2000-06-06
JPH04504123A (ja) 1992-07-23

Similar Documents

Publication Publication Date Title
DK0463064T3 (da) Neuronale nicotinacethylcholinreceptorsammensætninger indeholdende beta-4-underenheden
IL76580A0 (en) Preparation of strains of bacillus thuringiensis having entomocidal activity,a novel strain produced thereby,entomocidal substances derived from said strains and its use
PT81589A (en) Process for the preparation of tricyclo compounds useful for treating and preventing resistence by transplantation and other diseases
PH19006A (en) Process for the preparation of new optically active 1,4-dihydropyridine
FR2603586B1 (fr) Composes derives de l'imidazoquinolinylether, et leur procede de preparation
NO179518C (no) AnalogifremgangsmÕte for fremstilling av 2- hydroksymetylcytosin-substituerte 1,3-oksatiolaner
IL84381A0 (en) Process for the genetic modification of monocotyledonous plants
ATE57676T1 (de) Verfahren zur herstellung von carbid-boriderzeugnissen und deren verwendung.
FI880467A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
DE68922327T2 (de) Verfahren zur Herstellung von Vliesstoffen aus Kohlenstoffasern.
MA21588A1 (fr) Derives d'ether de n-pheryl pyrazole-4-yle, compositions les contenant et leur procede de preparation.
GB2211845B (en) Process for dechlorinating 4,5-dichlorofluoro-dioxolanes to obtain fluorodioxoles
ES452290A1 (es) Procedimiento para la preparacion de 1,4-bis (azolil-(2)- naftalina.
FR2512442B1 (fr) Derives de cyclopentadiene, procede de leur preparation, composition les contenant et procede de fabrication d'articles moules les utilisant
NO176098C (no) Analogifremgangsmåte for fremstilling av 2-substituerte N,N'-ditrimetoksybenzoyl-piperaziner
EP0272174A3 (fr) Préparations d'adenyl cyclase purifiées, procédé d'obtention de ces préparations et leurs applications biologiques
FR2574429B1 (fr) Acylglycannes extraits de klebsiella, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
OA08699A (fr) Aminopropionamides substitués, procédé pour leur préparation, produits les contenat et leur utilisation, ainsi que de nouveaux produit intermediaires pour leur préparation.
IT8720436A0 (it) Processo per la preparazione del 2,4-diammino-6-(1-piperidinil)-piri mi-din-n-ossido.
EP0344979A3 (en) Alfa-adrenergic receptor antagonists
DE3563436D1 (en) Methyl substituted bicyclo ad2.2.1 bdheptane nitriles, process for production of these nitriles and their use as scents
MA21530A1 (fr) Nouveaux composes contenant le cycle betalactame, et leur procede de preparation .
FR2561553B1 (fr) Composition de liant refractaire et son procede d'obtention
Hagiopol et al. Study of Azeotropy in Ternary Copolymerization. IV. Pseudoazeotropy
OA08257A (fr) Nouvemmes carboxamidoguanidines, leur procédé d'obtention et les compositions pharmaceutiques en renfermant.